Osaka Cardiometabolic Epidemiological Study: Ohtori Study Part 2
Launched by OSAKA METROPOLITAN UNIVERSITY · Nov 15, 2024
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
The Osaka Cardiometabolic Epidemiological Study, specifically the Ohtori Study Part 2, is looking to understand how the distribution of body fat in people affects their risk of developing metabolic and heart diseases. This study is focused on Japanese men and women and will use CT scans to measure body fat, along with other tests to discover new risk factors for these health issues.
The study is currently recruiting participants aged 30 and older, regardless of gender. If you join the study, you can expect to undergo some tests and assessments that will help researchers gather important information. It's important to note that women who might be pregnant are not eligible to participate. This research aims to help improve our understanding of how body fat and other factors contribute to conditions like diabetes, obesity, and heart disease.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • -
- Exclusion Criteria:
- • Women who may be pregnant
About Osaka Metropolitan University
Osaka Metropolitan University is a leading academic institution in Japan that emphasizes innovative research and development in the field of healthcare. As a clinical trial sponsor, the university leverages its extensive expertise in biomedical sciences and collaboration with multidisciplinary teams to advance medical knowledge and improve patient outcomes. The institution is committed to conducting rigorous and ethically sound clinical trials that contribute to the understanding of various diseases and the efficacy of new treatments, thereby fostering advancements in public health and clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Sakai, Osaka, Japan
Patients applied
Trial Officials
Tomoshige Hayashi, MD, PhD
Principal Investigator
Osaka Metropolitan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported